BioNTech SE ADR buy Theodosis
Start price
07.12.20
/
50%
€104.32
Target price
07.12.21
€120.00
Performance (%)
218.35%
End price
08.08.21
€332.10
Summary
This prediction ended on 08.08.21 with a price of €332.10. The BUY prediction by Theodosis for BioNTech SE ADR saw massive gains of 218.35%. Theodosis has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
According to Theodosis what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
positive Cash Flow expected
Normal challenges to pay loans and raise capital
Growths much faster than the competition
Cons
Comments by Theodosis for this prediction
In the thread Biontech SE diskutieren
Buy with target price 120.0